SEC Filing Analysis: Nuo Therapeutics, Inc. (AURX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director executed a "net exercise" of stock options, resulting in a net acquisition of 40,909 shares of common stock.
• Market Impact: The transaction is a routine exercise of derivative securities and is not considered a significant indicator of insider sentiment.

Company Information

Field	Value
Company	Nuo Therapeutics, Inc.
Ticker Symbol	AURX
CIK	0001091596
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	Mintz Paul
CIK	0001480208
Title/Position	Not Specified
Relationship	Director

Transaction Details

The filing reports a multi-part transaction known as a net exercise.

• Part 1 (Acquisition): Exercise of options to acquire 50,000 shares.
• Part 2 (Disposition): Withholding of 9,091 shares to cover the exercise price.
• Net Result: Acquisition of 40,909 shares.

Field	Value (for primary acquisition)
Form Type	4
Transaction Date	2025-12-09
Transaction Code	M (Exercise) / F (Withholding)
Security Type	Common Stock
Shares Involved	50,000 (Acquired via exercise)
Price Per Share	$0.40 (Exercise price)
Total Value	$20,000 (Cost of exercise)
Shares Owned After	108,294
Ownership Type	Direct

Financial Impact Assessment

Market capitalization and shares outstanding data were not available for a full materiality assessment. The analysis is based on the transaction's absolute value and nature.

Impact Evaluation

• Transaction Significance: The transaction is a cashless exercise of options, a common practice for insiders to acquire shares without a cash outlay. The total cost of the exercise was $20,000. The insider did not sell additional shares on the open market, retaining the net shares acquired. Given the nature and low dollar value, the significance is low.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Option exercises, especially when coupled with a withholding for cost purposes, are not typically interpreted as new investment decisions by the insider. They are the realization of previously granted compensation and do not signal new confidence in the same way an open-market purchase would.

Volume & Sentiment

• Expected Volume Impact: Minimal. The transaction did not involve open market trades.
• Sentiment Indicator: Neutral. This is a routine compensation-related transaction.

Additional Context

Transaction Notes

• Special Circumstances: The filing's footnote explicitly states this was a "net exercise" of stock options. The company withheld 9,091 shares to pay the $0.40 per share exercise price, based on a market price of $2.20 per share. The insider received the net difference of 40,909 shares.